COVIran Barekat
Expression error: Unexpected < operator.Expression error: Unexpected < operator.Expression error: Unexpected < operator.
 A vial of COVIran Barakat | |
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Killed/Inactivated |
| Clinical data | |
| Synonyms | COVIRAN کووایران برکت |
| Routes of administration | Intramuscular |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| E number | |
| ECHA InfoCard | |
COVIran Barekat[1] is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, part of the Barkat Pharmaceutical Group.[2][3][4] It is an inactivated virus-based vaccine.[1] Iranian authorities authorized its emergency use. It is the first locally developed COVID-19 vaccine to be approved for emergency use in the Middle East.[5]
COVIran Barekat Media
First production line, March 2021
COVIran Barekat -- Phases II and III of the clinical trials
References
- ↑ 1.0 1.1 Iran hopes to defeat COVID with home-grown crop of vaccines. Nature 596 (7873) (August 2021). p. 475. doi:10.1038/d41586-021-02216-z.
- ↑ COVIran Barakat: Iran launches human trials of its COVID vaccine. Al Jazeera (29 December 2020).
- ↑ Iran's leader gets locally made coronavirus vaccine shot (in en). Reuters (2021-06-25). Retrieved 2021-08-24.
- ↑ About - شرکت گروه صنایع شفافارمد (in en-US) (2021-04-15). Retrieved 2021-09-03.
- ↑ Iran issues license on its coronavirus vaccine (in en). Trend.Az (14 June 2021). Retrieved 14 June 2021.
